Cytotherapy

Pathology and Medical Technology

Cytotherapy

Editor in Chief: John Barrett, MD
Organizational Affiliations: International Society for Cellular Therapy (ISCT)

Cytotherapy is the Official Journal of the International Society for Cellular Therapy (ISCT).

Cytotherapy publishes cutting edge findings, clinical trials of cell-based therapies, and news and opinion on all aspects of the rapidly expanding field of cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation. The journal focuses especially on the practical translation of scientific developments in the laboratory into clinical practice. Cytotherapy is an essential global resource for clinical researchers, oncologists, hematologists, physicians, and regulatory experts involved in cell processing and therapy.

The journal's scope includes research in:

• Stem cell processing and transplantation
• Cell-based therapies of malignant and non-malignant blood diseases
• Cancer
• Stem cell plasticity
• Autoimmune diseases
• Immunotherapy
• Congenital disorders
• Novel molecular therapies
• Gene therapy
• Microvesicle biology and therapeutic application

Global Print Circulation
309
Avg. Global Monthly Visits
19,814
Avg. Global Monthly Unique Visitors
8,966
Avg. Global Monthly Page Views
11,618
Avg. Global eTOC Distribution
8,097
Circulation updated on 1st July, 2023, based on 12-month monthly average July 2022-June 2023, eTOC Metrics: 12 Month Average of eTOC sends - July 2022 to June 2023, Monthly average web metrics based on the period of July 2022 to June 2023

Rate Card

Find the best value for your advertising dollars

Journal Website

Find out more directly from the source

Journal Metrics

Detailed insights into the reach and penetration of this journal

Have a question or need assistance?